Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HTR1D | P28221 | 1/20 | 0.44 |
| ▸ | HTR1B | P28222 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | KCNB1 | Q14721 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30083263 | 1.00 | CYP1A2 (0.45) | CYP1A2CYP2C19CYP2D6ALDH1A1L3MBTL1 | |
| SCHEMBL30083121 | 0.91 | KCNB1 (0.49) | CYP1A2CYP2C19CYP2D6HTR1DHTR1B | |
| SCHEMBL24731946 | 0.91 | KCNB1 (0.49) | CYP1A2CYP2C19CYP2D6HTR1DHTR1B | |
| SCHEMBL24731947 | 0.91 | KCNB1 (0.49) | CYP1A2CYP2C19CYP2D6HTR1DHTR1B | |
| SCHEMBL24731387 | 0.88 | HSP90AA1 (0.45) | CYP1A2CYP2C19CYP2D6ALDH1A1L3MBTL1 | |
| SCHEMBL31218100 | 0.88 | HSP90AA1 (0.45) | CYP1A2CYP2C19CYP2D6ALDH1A1L3MBTL1 | |
| SCHEMBL31218079 | 0.88 | KCNK3 (0.47) | CYP1A2CYP2C19CYP2D6ALDH1A1KCNB1 | |
| SCHEMBL24731388 | 0.88 | KCNK3 (0.47) | CYP1A2CYP2C19CYP2D6ALDH1A1KCNB1 | |
| SCHEMBL31218101 | 0.87 | CYP1A2 (0.44) | CYP1A2CYP2C19CYP2D6HTR1DHTR1B | |
| SCHEMBL31218049 | 0.87 | CTSK (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240383852-A1 | ANTI-VIRAL COMPOUNDS | Infex Therapeutics Limited (GB) | 2024-11-21 | — | — | US | disclosed |
| EP-4305022-A1 | ANTI-VIRAL COMPOUNDS | Infex Therapeutics Limited (GB) | 2024-01-17 | — | — | EP | disclosed |
| CN-117396462-A | Antiviral compounds | 英菲克斯治疗有限公司 | 2024-01-12 | — | — | CN | disclosed |
| WO-2022189810-A1 | ANTI-VIRAL COMPOUNDS | Infex Therapeutics Limited (GB) | 2022-09-15 | — | — | WO | disclosed |
| WO-2022189810-A1 | ANTI-VIRAL COMPOUNDS | Infex Therapeutics Limited (GB) | 2022-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383852-A1 | ANTI-VIRAL COMPOUNDS | PREP, DNPEP, PLP2 | CYP1A2 4023/4885CYP2C19 3962/4885CYP2D6 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.